Pages that link to "Q422273"
Jump to navigation
Jump to search
The following pages link to clindamycin (Q422273):
Displaying 50 items.
- malaria (Q12156) (← links)
- staphylococcal infection (Q34879) (← links)
- World Health Organization Model List of Essential Medicines (Q37155) (← links)
- syphilis (Q41083) (← links)
- Lemierre's syndrome (Q72000) (← links)
- acne (Q79928) (← links)
- botulism (Q154865) (← links)
- toxoplasmosis (Q154878) (← links)
- scarlet fever (Q180266) (← links)
- sinusitis (Q183344) (← links)
- tonsillitis (Q186470) (← links)
- campylobacteriosis (Q683861) (← links)
- Babesiosis (Q797668) (← links)
- bacterial vaginosis (Q804521) (← links)
- cellulitis (Q876887) (← links)
- erysipelothrix rhusiopathiae infectious disease (Q1607983) (← links)
- skin infection (Q2458539) (← links)
- dental abscess (Q2710164) (← links)
- benzoyl peroxide/clindamycin (Q4890807) (← links)
- pneumocystosis (Q7205993) (← links)
- bacteroides infectious disease (Q18975970) (← links)
- Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial (Q21134701) (← links)
- (Q21850534) (redirect page) (← links)
- Clindamycin as an antimalarial drug: review of clinical trials (Q24536057) (← links)
- Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin (Q24601968) (← links)
- Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh [...] (Q24643277) (← links)
- Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria (Q24680404) (← links)
- Profile of clindamycin phosphate 1.2%/benzoyl peroxide 3.75% aqueous gel for the treatment of acne vulgaris (Q26775849) (← links)
- Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii (Q28216484) (← links)
- Fox-Fordyce disease treated with topical clindamycin solution (Q28290337) (← links)
- Tobramycin and clindamycin in the treatment of febrile leukaemic patients (Q28319726) (← links)
- Clindamycin in the treatment of human ocular toxoplasmosis (Q28332502) (← links)
- Renal failure following gentamicin in combination with clindamycin (Q28334015) (← links)
- The Spectrum of Colitis Associated with Lincomycin and Clindamycin Therapy (Q28338062) (← links)
- Clindamycin allergy presenting as rosacea (Q28341803) (← links)
- Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate (Q28359157) (← links)
- Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo (Q28361289) (← links)
- Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis (Q28365511) (← links)
- Ventricular fibrillation due to long QT syndrome probably caused by clindamycin (Q28371793) (← links)
- Neuromuscular blockade after clindamycin administration: a case report (Q28375527) (← links)
- Treatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosis (Q28379387) (← links)
- Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam (Q28534525) (← links)
- Clindamycin therapy of experimental Staphylococcus aureus endocarditis (Q30451367) (← links)
- Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies (Q30794322) (← links)
- The pseudomembranous colitis associated with clindamycin therapy--a viral colitis (Q30830205) (← links)
- Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents (Q30832465) (← links)
- High rate of non-susceptibility to metronidazole and clindamycin in anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan (Q30914509) (← links)
- Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcusspp. infection after cerebrospinal fluid diversion procedures (Q30990259) (← links)
- Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. (Q31918412) (← links)
- Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction (Q32115826) (← links)